Insider Transactions in Q3 2025 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Julie Hambleton Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,155
-100.0%
|
-
|
|
Jul 01
2025
|
Freda C Lewis Hall Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,727
-100.0%
|
-
|
|
Jul 01
2025
|
Daniel Lynch Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
93,004
-100.0%
|
-
|
|
Jul 01
2025
|
Badreddin Edris Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
169,712
-100.0%
|
-
|
|
Jul 01
2025
|
Michael Nofi Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
30,623
-100.0%
|
-
|
|
Jul 01
2025
|
Carlos Alban Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,861
-100.0%
|
-
|
|
Jul 01
2025
|
Martin Mackay Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,023
-100.0%
|
-
|
|
Jul 01
2025
|
James Cassidy Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
81,731
-100.0%
|
-
|
|
Jul 01
2025
|
Bhavesh Ashar Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,053
-100.0%
|
-
|
|
Jul 01
2025
|
Tai An Lin Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,039
-100.0%
|
-
|
|
Jul 01
2025
|
Alan Fuhrman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
24,727
-100.0%
|
-
|
|
Jul 01
2025
|
Herschel S Weinstein General Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
55,239
-100.0%
|
-
|
|
Jul 01
2025
|
Saqib Islam Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
954,869
-100.0%
|
-
|
|
Jul 01
2025
|
Perier I Francis Jr Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
60,889
-100.0%
|
-
|
|
Jul 01
2025
|
Daniel Pichl Chief People Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
50,762
-100.0%
|
-
|